Thank you to our Foundational and Sustaining members
2019 has not been a banner year for Minnesota’s M&A market. After a half-decade of record-setting activity, the local M&A scene has cooled significantly, with the lowest reported deal volume and dollar values since 2013. According to Pitchbook data, total deal count for Minnesota companies for the first half of 2019 was 35% lower than over […]
Clean air is probably something that most Minnesotans take for granted. But not everyone has that luxury. The World Health Organization estimates that 4.2 million people die each year as a result of exposure to outdoor air pollution – more than Malaria and contaminated drinking water. A group of medical entrepreneurs in the Twin Cities hopes to a new provide a […]
New Minnesota-based medical device company focuses on biological medical devices manufactured using perfusion decellularization technology. Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from […]
Brian Brockway is the founder of Data Sciences Intl. (DSI), the leading provider of wireless implantable sensors and systems for preclinical testing of new drugs and biomedical research. He bootstrapped DSI with SBIR grants into a highly profitable business with over $40 million in revenue where he developed domestic and international direct sales and distribution […]
Minneapolis/June 4, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio of products that serve […]
Andres J. Acosta, M.D., Ph.D., focuses his research on gastrointestinal physiology to understand the complexity of food intake regulation and obesity. Obesity is a primary cause of type 2 diabetes, fatty liver disease, cardiovascular disease and cancer. Dr. Acosta’s laboratory utilizes a combination of genetics, physiology, pharmacology, proteomics, metabolomics, and gastrointestinal and brain imaging to […]
Medical Alley Association is excited to announce another set of resources available to our startup members through our partnership with Google Cloud for Startups, a program that connects startup and early-stage companies with the resources they need to build and grow their business. What is Google Cloud for Startups? The Google Cloud for Startups program […]
Healthcare’s Move from Volume to Value Fuels Startup Investment As industry leaders work to redefine value in healthcare, payers and providers are offering access to the once-impenetrable healthcare marketplace for new technologies. As large healthcare systems and payers expand their own investment portfolios, they are becoming familiar with the value that startups can drive and […]
Records Fall in Q1 As Money Flows Into Medical Alley’s Startup and Growth-Stage Companies After setting a record with their best-ever Q1 in 2018, Medical Alley startup companies didn’t just set the record again, they shattered it! For the third consecutive year, Medical Alley startup and growth-stage companies broke the previous record for money raised […]
Medical Alley Association is very excited to announce that our members now have access to AWS Activate, a program that connects startup and early-stage companies with the resources they need to build and grow their business. What is the AWS Activate Program? Amazon Web Services provides startups with the low-cost, easy-to-use infrastructure needed to scale […]